Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial

• Main Authors: Watanabe, S., Rathore, A.P.S., Sung, C., Lu, F., Khoo, Y.M., Connolly, J., Low, J., Ooi, E.E., Lee, H.S., Vasudevan, S.G.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: 2014
• Subjects: AG129 lethal infection mouse model; Antiviral; Dengue virus; Pharmacokinetics
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/110037
• Institution: National University of Singapore

10.1016/j.antiviral.2012.07.008